VCM
SCMP

Vivaldi Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Vivaldi Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-20,822
Closed -$374K – 158
2017
Q4 		$374K Buy
+20,822
New +$256K 0.31% 83

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Vivaldi Capital Management's SCMP Position: Q1 2018 in Review

Vivaldi Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 20,822 shares — an estimated $374K sold.

Vivaldi Capital Management first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $374K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Vivaldi Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Vivaldi Capital Management sold 20,822 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $374K.
  • Vivaldi Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • Vivaldi Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $374K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Vivaldi Capital Management's 13F filing for Q1 2018, filed 8 May 2018.